Leah Hayden, NP
Acute Care · Anchorage, AKNPI 1801585070
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.6%), food and beverage and education — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 65.2% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $1,563, 3.9 times the $398 reported in 2023.
Across 26 payments — averaging $99.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Medtronic$414
- E.r. Squibb & Sons, L.L.C.$165
- Impulse Dynamics (USA) Inc.$154
- Novartis$125
- AstraZeneca$41
What the payments were for
- Travel & lodging$1,20547%
- Food & beverage$96537%
- Education$41416%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $1,685 |
| Medtronic | 9 | $414 |
| E.r. Squibb & Sons, L.L.C. | 5 | $165 |
| Impulse Dynamics (USA) Inc. | 1 | $154 |
| Novartis | 1 | $125 |
| AstraZeneca | 2 | $41 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$1,329
- OPTIMIZER$307
- LEQVIO$125
- CAMZYOS$109
How this compares
Too few acute care providers in Alaskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 178 | $273,217 |
| MultaqDronedarone Hcl | 26 | $44,105 |
| XareltoRivaroxaban | 27 | $43,324 |
| Metoprolol Succinate | 113 | $2,491 |
| Nebivolol Hcl | 11 | $818 |
| Losartan Potassium | 34 | $598 |
| Carvedilol | 50 | $570 |
| Atorvastatin Calcium | 33 | $517 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 28 | $505 |
| Verapamil ErVerapamil Hcl | 12 | $504 |
| Amiodarone Hcl | 16 | $493 |
| Lisinopril | 25 | $212 |
| Metoprolol Tartrate | 28 | $182 |
| Spironolactone | 11 | $171 |
| Amlodipine Besylate | 20 | $92 |
Paid to pharmacies, not to this prescriber.
Other acute care in Anchorage
- Lorie PettyAnchorage$2K
- Micah RobertAnchorage$667
- Jorin CaltAnchorage$335
- Sarah MorehouseAnchorage$292
- Lisa PageAnchorage$261
- Kimberly RevelsAnchorage$253
- Kelly St JohnAnchorage$159
- Geoffrey MittelsteadtAnchorage$127
- Claudia SmithAnchorage$81
- Rosemary TimmermanAnchorage$42
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.